AK

Anand Kumar Verma

Active Director Director DIN 08060472
DIN 08060472 First appointment Feb 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Anand Kumar Verma

Data last updated:

Anand Kumar Verma is a Director at Greek Pharma Private Limited (since 2018). The company operates in Pharma. Greek Pharma Private Limited reported revenue of ₹2.29 Cr (FY 2025).

DIN 08060472
Primary Designation Director
Industry Pharma
First Appointment 23 Feb 2018
Oldest Company Age 8 yrs
Largest company Greek Pharma Private Limited · ₹2.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Greek Pharma Private Limited U51909HR2018PTC072707
Director23 Feb 20182018₹2.29 Cr (FY 2025)Active

Board colleagues of Anand Kumar Verma

NameDINCompanyDesignation
Hament Kumar08060458Greek Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Greek Pharma Private Limited
Premium access

Shareholding and investment profile for Anand Kumar Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Kumar Verma

Anand Kumar Verma currently holds 1 directorship: Greek Pharma Private Limited (Director, since 23 Feb 2018, revenue ₹2.29 Cr (FY 2025)).

Anand Kumar Verma was first appointed on 23 Feb 2018 as Director at Greek Pharma Private Limited.

The current boards of Anand Kumar Verma's companies include Hament Kumar (Greek Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available